Tunis hosts 2nd Precision Medicine Academy, April 15-18


Tunis: Tunis will host the 2nd Precision Medicine Academy (PMA- 2nd edition), organised by the Institut Pasteur de Tunis on April 15-18, 2024, as part of the training activities of the Personalised Medicine in North Africa (PerMediNA) project, with the participation of 120 medical specialists and researchers.

The Precision Medicine Academy comprises a set of lectures and interactive sessions led by leading experts in the precision medicine field.

The Academy will begin with an update on the progress of the PerMediNA project and the setting up of the Molecular Multidisciplinary Consultation Meetings and Functional Genomics Task Forces.

Other topics to be addressed, via training workshops and/or feedback, include the development of skills in leadership, mentorship, project management, scientific writing and communication, as well as other issues necessary for the career development of young researchers and healthcare staff, in addition to the involvement of the pharmaceutical industry and political decision-
makers, the health economy and its importance in the well-being of patients.

This second edition will focus on four main themes: a look back at the Academy of Precision Medicine and updates on the project, feedback from young researchers during internships and training courses with collaborators, workshops dedicated to developing skills such as communication and leadership, and an opening-up to other African initiatives.

The PerMediNA project is coordinated by the Institut Pasteur de Tunis and involves four Pasteur Network members: the Institut Pasteur de Tunis, the Institut Pasteur d’AlgĂ©rie, the Institut Pasteur du Maroc and the Institut Pasteur de Paris.

The project aims to set up a Maghreb consortium for applied precision medicine in oncology.

PerMediNA is a founding project that marks an important step in structuring precision medicine in North Africa, enhancing collaboration between Pasteur Network members in the region and improving patient care by facilitating access to genetic tests and targeted
therapy.

Source: Agence Tunis Afrique Presse